ALPS Medical Breakthroughs ETF (SBIO)
| Assets | $104.13M |
| Expense Ratio | 0.50% |
| PE Ratio | n/a |
| Shares Out | 3.10M |
| Dividend (ttm) | $0.07 |
| Dividend Yield | 0.22% |
| Ex-Dividend Date | Dec 21, 2023 |
| Payout Ratio | n/a |
| 1-Year Return | +5.06% |
| Volume | 1,662 |
| Open | 33.73 |
| Previous Close | 33.79 |
| Day's Range | 32.90 - 33.73 |
| 52-Week Low | 23.21 |
| 52-Week High | 38.80 |
| Beta | 1.12 |
| Holdings | 105 |
| Inception Date | Dec 31, 2014 |
About SBIO
Fund Home PageThe ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is issued by SS&C.
Top 10 Holdings
27.45% of assets| Name | Symbol | Weight |
|---|---|---|
| Krystal Biotech, Inc. | KRYS | 3.88% |
| Alkermes plc | ALKS | 3.07% |
| Immunovant, Inc. | IMVT | 2.99% |
| Avidity Biosciences, Inc. | RNA | 2.94% |
| Crinetics Pharmaceuticals, Inc. | CRNX | 2.71% |
| Merus N.V. | MRUS | 2.69% |
| Corcept Therapeutics Incorporated | CORT | 2.53% |
| Denali Therapeutics Inc. | DNLI | 2.34% |
| Amicus Therapeutics, Inc. | FOLD | 2.16% |
| Arcellx, Inc. | ACLX | 2.14% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 21, 2023 | $0.07106 | Dec 27, 2023 |
| Dec 19, 2019 | $0.01585 | Dec 27, 2019 |
| Dec 20, 2018 | $0.78406 | Dec 27, 2018 |
| Dec 21, 2017 | $0.57949 | Dec 28, 2017 |
News
Big Pharma Has the Firepower for Biotech Deal-Making
In the early innings of 2024, there was a flurry of consolidation in the biotech industry. It stoked hopes that this would finally be the year in which well-heeled blue-chip pharmaceutical companies w...
Biopharma R&D Trends Could Bode Well for This ETF
Many investors hoping for a resurgence by biotech stocks have hitched their wagons to the Federal Reserve lowering interest rates. That's a practical bet because biotech is a rate-sensitive industry.
Vector Space Biosciences (SBIO) Is Now Available for Trading on LBank Exchange
Road Town, Virgin Islands--(Newsfile Corp. - September 24, 2023) - LBank Exchange, a global digital asset trading platform, listed Vector Space Biosciences (SBIO) on September 15, 2023. For all users ...
